Using a Self-Administered Electronic Adherence Questionnaire to Identify Poor Adherence Amongst Adolescents and Young Adults on First-Line Antiretroviral Therapy in Johannesburg, South Africa

References

• Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic; 2013. Available from: http://files.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic; 2012. Available from: http://www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Report_2012_with_annexes_en_1.pdf
   Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV & AIDS statistics — 2019 fact sheet 2019. Available from: http://www.unaids.org/en/resources/fact-sheet.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). Update - Active involvement of young people is key to ending the AIDS epidemic by 2030. Available from: https://www.unaids.org/en/resources/presscentre/featurestories/2015/august/20150812_PACT. Accessed December 16, 2019.
   Google Scholar
• Machado JK, Sant’Anna MJ, Coates V, et al. Brazilian adolescents infected by HIV: epidemiologic characteristics and adherence to treatment. Sci World J. 2009;9:1273–1285. doi:10.1100/tsw.2009.136
   Web of Science ®Google Scholar
• Mavedzenge SMN, Doyle AM, Ross DA. HIV prevention in young people in sub-Saharan Africa: a systematic review. J Adolesc Health. 2011;49(6):568–586. doi:10.1016/j.jadohealth.2011.02.007
   PubMed Web of Science ®Google Scholar
• Sawyer SM, Afifi RA, Bearinger LH, et al. Adolescence: a foundation for future health. Lancet. 2012;379(9826):1630–1640. doi:10.1016/S0140-6736(12)60072-5
   PubMed Web of Science ®Google Scholar
• Schwarz SW. Adolescent Reproductive and Sexual Health: Facts for Policymakers. 2010. Available from: http://www.nccp.org/publications/pdf/text_931.pdf. Accessed December 16, 2019.
   Google Scholar
• Bygrave H, Mtangirwa J, Ncube K, et al. Antiretroviral therapy outcomes among adolescents and youth in rural Zimbabwe. PLoS One. 2012;7(12):e52856. doi:10.1371/journal.pone.0052856
   PubMed Web of Science ®Google Scholar
• Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses. 2013;29(6):892–900. doi:10.1089/aid.2012.0215
   PubMed Web of Science ®Google Scholar
• Janssen N, Ndirangu J, Newell M-L, Bland RM. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2009. p. adc. 2009.169367.
   Web of Science ®Google Scholar
• Nglazi MD, Kranzer K, Holele P, et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect Dis. 2012;12(1):21. doi:10.1186/1471-2334-12-21
   PubMed Web of Science ®Google Scholar
• Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245. doi:10.1007/s10461-006-9078-6
   PubMed Web of Science ®Google Scholar
• Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low-and middle-income countries. Pediatr Infect Dis J. 2008;27(8):686–691. doi:10.1097/INF.0b013e31816dd325
   PubMed Web of Science ®Google Scholar
• Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–977. doi:10.7326/0003-4819-134-10-200105150-00011
   PubMed Web of Science ®Google Scholar
• Adefolalu AO, Nkosi ZZ. The complex nature of adherence in the management of HIV/AIDS as a chronic medical condition. Diseases. 2013;1(1):18–35. doi:10.3390/diseases1010018
   Google Scholar
• Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials. 2011;12(5):244–254. doi:10.1310/hct1205-244
   PubMed Web of Science ®Google Scholar
• Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010;14(6):1294–1301. doi:10.1007/s10461-010-9720-1
   PubMed Web of Science ®Google Scholar
• Gnambs T, Kaspar K. Disclosure of sensitive behaviors across self-administered survey modes: a meta-analysis. Behav Res Methods. 2015;47(4):1237–1259. doi:10.3758/s13428-014-0533-4
   PubMed Web of Science ®Google Scholar
• Glass TR, Sterne JA, Schneider M-P, et al. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. Aids. 2015;29(16):2195–2200. doi:10.1097/QAD.0000000000000782
   PubMed Web of Science ®Google Scholar
• Metzner KJ, Giulieri SG, Knoepfel SA, et al. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and-adherent patients. Clin Infect Dis. 2009;48(2):239–247. doi:10.1086/595703
   Web of Science ®Google Scholar
• Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112–1118. doi:10.1086/378301
   PubMed Web of Science ®Google Scholar
• Department of Health Republic of South Africa. National consolidated guidelines – for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults; 2015. Available from: http://www.sahivsoc.org/Files/ART%20Guidelines%2015052015.pdf.
   Google Scholar
• Kredo T, Van der Walt JS, Siegfried N, Cohen K. Therapeutic drug monitoring of antiretrovirals for people with HIV. In: Cochrane Database of Systematic Reviews. 2009:3.
   Google Scholar
• Pretorius E, Klinker H, Rosenkranz B. The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection. Ther Drug Monit. 2011;33(3):265–274. doi:10.1097/FTD.0b013e31821b42d1
   PubMed Web of Science ®Google Scholar
• van Luin M, Kuks PF, Burger DM. Use of therapeutic drug monitoring in HIV disease. Curr Opin HIV AIDS. 2008;3(3):266–271. doi:10.1097/COH.0b013e3282f82c1b
   PubMed Web of Science ®Google Scholar
• Feghali M, Venkataramanan R, Caritis S, editors. Pharmacokinetics of drugs in pregnancy. In: Seminars in Perinatology. Elsevier; 2015;39(7):512–9.
   Google Scholar
• Olagunju A, Bolaji O, Amara A, et al. Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics. Clin Pharmacol Ther. 2015;97(3):298–306. doi:10.1002/cpt.43
   Web of Science ®Google Scholar
• Department of Health Republic of South Africa. National antiretroviral treatment guidelines. 2004. Available from: http://www0.sun.ac.za/ruralhealth/ukwandahome/rudasaresources2009/DOH/1.%20Antiretroviral.pdf.
   Google Scholar
• Department of Health Republic of South Africa. Circular on new criteria for initiating adults on ART at CD4 count of 350 cells/mL and below. 2011. [letter].
   Google Scholar
• Department of Health Republic of South Africa. National antiretroviral treatment guidelines; 2013. Available from: http://www.sahivsoc.org/Files/2013%20ART%20Guidelines-Short%20Combined%20FINAL%20draft%20guidelines%2014%20March%202013.pdf.
   Google Scholar
• Department of Health Republic of South Africa. Implementation of the universal test and treat strategy for HIV positive patients and differentiated care for stable patients 2016. Available from: http://www.sahivsoc.org/Files/22%208%2016%20Circular%20UTT%20%20%20Decongestion%20CCMT%20Directorate.pdf.
   Google Scholar
• Fox MP, Maskew M, MacPhail AP, et al. Cohort profile: the themba lethu clinical cohort, Johannesburg, South Africa. Int J Epidemiol. 2013;42:2. doi:10.1093/ije/dys029
   Web of Science ®Google Scholar
• Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA study. Aids. 2002;16(4):605–613. doi:10.1097/00002030-200203080-00012
   PubMed Web of Science ®Google Scholar
• Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79. doi:10.1097/01.qai.0000248337.97814.66
   PubMed Web of Science ®Google Scholar
• Zerion Software. Best apps for data collection 2018; 2018. Available from: https://www.zerionsoftware.com/best-apps-for-data-collection/.
   Google Scholar
• Mbengue MAS, Chasela C, Onoya D, Mboup S, Fox MP, Evans D. Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa. Clin Epidemiol. 2019;11:359. doi:10.2147/CLEP.S197741
   Web of Science ®Google Scholar
• Chan D. So why ask me? Are self-report data really that bad. Statistical and Methodological Myths and Urban Legends: Doctrine, Verity and Fable in the Organizational and Social Sciences. 2009;309–336.
   Google Scholar
• Trau RN, Härtel CE, Härtel GF. Reaching and hearing the invisible: organizational research on invisible stigmatized groups via web surveys. Br J Manage. 2013;24(4):532–541. doi:10.1111/j.1467-8551.2012.00826.x
   Web of Science ®Google Scholar
• Ye C, Fulton J, Tourangeau R. More positive or more extreme? A meta-analysis of mode differences in response choice. Public Opin Q. 2011;75(2):349–365. doi:10.1093/poq/nfr009
   Web of Science ®Google Scholar
• Li JZ, Etemad B, Ahmed H, et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 2016;30(3):343.
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015.
   Web of Science ®Google Scholar
• Boullé C, Guichet E, Kouanfack C, et al. editors. Virologic failure and human immunodeficiency virus drug resistance in rural Cameroon with regard to the UNAIDS 90- 90-90 Treatment targets. In:Open Forum Infectious Diseases. Oxford University Press; 2016.
   Google Scholar
• Zuo Z, Liang S, Sun X, et al. Drug resistance and virological failure among HIV-infected patients after a decade of antiretroviral treatment expansion in eight provinces of China. PLoS One. 2016;11(12):e0166661. doi:10.1371/journal.pone.0166661
   Web of Science ®Google Scholar
• Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Supplement_3):S272–S278. doi:10.1086/533415
   Web of Science ®Google Scholar
• Enara M. Therapeutic drug monitoring (TDM) pitfalls and limitations. MOJ Toxicol. 2014;1(1):9–10. doi:10.15406/mojt
   Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885
   PubMed Web of Science ®Google Scholar